These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25774821)

  • 61. Transperitoneal versus extraperitoneal robot-assisted laparoscopic radical prostatectomy: A prospective single surgeon randomized comparative study.
    Akand M; Erdogru T; Avci E; Ates M
    Int J Urol; 2015 Oct; 22(10):916-21. PubMed ID: 26212891
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of a hydrogel spacer for improving quality of life in patients with prostate cancer undergoing low-dose-rate brachytherapy alone or in combination with intensity-modulated radiotherapy: An observational study using propensity score matching.
    Nakai Y; Tanaka N; Asakawa I; Ohnishi K; Miyake M; Yamaki K; Torimoto K; Fujimoto K
    Prostate; 2024 Sep; 84(12):1104-1111. PubMed ID: 38734992
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical characteristics of secondary bladder cancer developing after low-/high-dose-rate brachytherapy to treat localized prostate cancer.
    Miyajima K; Suzuki H; Urabe F; Iwatani K; Imai Y; Yasue K; Yanagisawa T; Kimura S; Tashiro K; Tsuzuki S; Koike Y; Miki J; Yuen S; Sasaki T; Aoki M; Sato S; Takahashi H; Miki K; Kimura T
    Int J Clin Oncol; 2023 Sep; 28(9):1200-1206. PubMed ID: 37432614
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Achieving Quality Assurance of Prostate Cancer Surgery During Reorganisation of Cancer Services.
    Cathcart P; Sridhara A; Ramachandran N; Briggs T; Nathan S; Kelly J
    Eur Urol; 2015 Jul; 68(1):22-9. PubMed ID: 25770482
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Impact of robot-assisted radical prostatectomy on health-related quality of life in patients with lower urinary tract symptoms.
    Choi EY; Jeong J; Kang DI; Johnson K; Ercolani M; Jang T; Lee DH; Kim WJ; Kim IY
    Int J Urol; 2011 Apr; 18(4):297-303. PubMed ID: 21342297
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Low dose brachytherapy with seeds--an interdisciplinary therapy alternative to radical prostatectomy].
    Kahmann F; Henkel T
    Praxis (Bern 1994); 2001 Sep; 90(36):1523-31. PubMed ID: 11593908
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Survivorship beyond convalescence: 48-month quality-of-life outcomes after treatment for localized prostate cancer.
    Gore JL; Kwan L; Lee SP; Reiter RE; Litwin MS
    J Natl Cancer Inst; 2009 Jun; 101(12):888-92. PubMed ID: 19509365
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A prospective study of oral 5-aminolevulinic acid to prevent adverse events in patients with localized prostate cancer undergoing low-dose-rate brachytherapy: Protocol of the AMBER study.
    Miyake M; Tanaka N; Asakawa I; Yamaki K; Inoue T; Suzuki S; Hori S; Nakai Y; Anai S; Torimoto K; Toritsuka M; Nakagawa H; Tsukamoto S; Fujii T; Ohbayashi C; Hasegawa M; Kasahara M; Fujimoto K
    Contemp Clin Trials Commun; 2020 Sep; 19():100593. PubMed ID: 32637724
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quality of life in young men after radical prostatectomy.
    Wright JL; Lin DW; Cowan JE; Carroll PR; Litwin MS;
    Prostate Cancer Prostatic Dis; 2008; 11(1):67-73. PubMed ID: 17519925
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Time course and predictors of symptoms after primary prostate cancer therapy.
    Talcott JA; Manola J; Clark JA; Kaplan I; Beard CJ; Mitchell SP; Chen RC; O'Leary MP; Kantoff PW; D'Amico AV
    J Clin Oncol; 2003 Nov; 21(21):3979-86. PubMed ID: 14581420
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of outcomes between pure laparoscopic vs robot-assisted laparoscopic radical prostatectomy: a study of comparative effectiveness based upon validated quality of life outcomes.
    Willis DL; Gonzalgo ML; Brotzman M; Feng Z; Trock B; Su LM
    BJU Int; 2012 Mar; 109(6):898-905. PubMed ID: 21933328
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Quality of life following treatment for early prostate cancer: does low dose rate (LDR) brachytherapy offer a better outcome? A review.
    Henderson A; Laing RW; Langley SE
    Eur Urol; 2004 Feb; 45(2):134-41. PubMed ID: 14733996
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stereotactic Body Radiotherapy versus Low Dose Rate Brachytherapy for Localised Prostate Cancer: a Cost-Utility Analysis.
    Helou J; Torres S; Musunuru HB; Raphael J; Cheung P; Vesprini D; Chung HT; D'Alimonte L; Krahn M; Morton G; Loblaw A
    Clin Oncol (R Coll Radiol); 2017 Nov; 29(11):718-731. PubMed ID: 28916284
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term incidence of secondary bladder and rectal cancer in patients treated with brachytherapy for localized prostate cancer: a large-scale population-based analysis.
    Mazzone E; Mistretta FA; Knipper S; Palumbo C; Tian Z; Pecoraro A; Preisser F; Gallina A; Shariat SF; Saad F; Graefen M; Montorsi F; Briganti A; Karakiewicz PI
    BJU Int; 2019 Dec; 124(6):1006-1013. PubMed ID: 31144770
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Communicating Value in Health Care Using Radar Charts: A Case Study of Prostate Cancer.
    Thaker NG; Ali TN; Porter ME; Feeley TW; Kaplan RS; Frank SJ
    J Oncol Pract; 2016 Sep; 12(9):813-20. PubMed ID: 27577622
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Counterpoint: Which Treatment Modality for Localized Prostate Cancer Yields Superior Quality of Life: Radiotherapy or Prostatectomy? Most Men With Clinically Important Localized Prostate Cancer Deserve First-Line Open or Robotic Radical Prostatectomy.
    Moul JW
    Oncology (Williston Park); 2017 Nov; 31(11):830, 833-5. PubMed ID: 29179252
    [No Abstract]   [Full Text] [Related]  

  • 77. [Sexual function after permanent seed implant prostate brachytherapy].
    Yagi Y; Namitome R; Kono Y; Nishiyama T; Toya K; Yorozu A; Saito S
    Nihon Hinyokika Gakkai Zasshi; 2012 Jul; 103(4):599-603. PubMed ID: 23120993
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy and Feasibility of Low-Dose Rate Brachytherapy for Prostate Cancer in Renal Transplant Recipients.
    Iizuka J; Hashimoto Y; Hashimoto Y; Kondo T; Takagi T; Nozaki T; Shimizu T; Akimoto T; Ishida H; Karasawa K; Tanabe K
    Transplant Proc; 2016 Apr; 48(3):910-3. PubMed ID: 27234765
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Image-guided robots for low dose rate prostate brachytherapy: Perspectives on safety in design and use.
    Dai X; Zhang Y; Jiang J; Li B
    Int J Med Robot; 2021 Jun; 17(3):e2239. PubMed ID: 33689202
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatments for prostate cancer in older men: 1984-1997.
    Bubolz T; Wasson JH; Lu-Yao G; Barry MJ
    Urology; 2001 Dec; 58(6):977-82. PubMed ID: 11744472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.